SCHEMBL356762

SCHEMBL356762

O=P(O)(O)O[C@@H]1[C@H](OP(=O)(O)O)[C@H](OP(=O)(O)O)[C@@H](O)[C@H](O)[C@H]1OP(=O)(O)O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
ITPR3 Q14573 8/20 1.00
ITPR2 Q14571 4/20 0.89
ITPR1 Q14643 4/20 0.89
INPP5A Q14642 2/20 0.84
INPPL1 O15357 1/20 0.84
AKT1 P31749 1/20 0.84
SMPD1 P17405 1/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8440404 1.00 ITPR3 (1.00) ITPR3ITPR2ITPR1INPP5AINPPL1
SCHEMBL12686382 1.00 ITPR3 (1.00) ITPR3ITPR2ITPR1INPP5AINPPL1
SCHEMBL1342025 1.00 ITPR3 (1.00) ITPR3ITPR2ITPR1INPP5AINPPL1
SCHEMBL513820 1.00 ITPR3 (1.00) ITPR3ITPR2ITPR1INPP5AINPPL1
SCHEMBL9439604 1.00 ITPR3 (1.00) ITPR3ITPR2ITPR1INPP5AINPPL1
SCHEMBL9439428 1.00 ITPR3 (1.00) ITPR3ITPR2ITPR1INPP5AINPPL1
SCHEMBL544343 1.00 ITPR3 (1.00) ITPR3ITPR2ITPR1INPP5AINPPL1
Atrinositol SCHEMBL9022890 0.97 ITPR3 (1.00) ITPR3ITPR2ITPR1INPP5AINPPL1
Atrinositol SCHEMBL180074 0.97 ITPR3 (1.00) ITPR3ITPR2ITPR1INPP5AINPPL1
Atrinositol SCHEMBL888326 0.97 ITPR3 (1.00) ITPR3ITPR2ITPR1INPP5AINPPL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 417 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3166572-B1 ANTI-CALCULUS ORAL COMPOSITIONS PROCTER & GAMBLE (US) 2019-05-01 EP claimed
EP-3166572-A1 ANTI-CALCULUS ORAL COMPOSITIONS The Procter and Gamble Company (US) 2017-05-17 EP claimed
US-20160008238-A1 Anti-Calculus Oral Compositions THE PROCTER & GAMBLE COMPANY 2016-01-14 US claimed
WO-2016004597-A1 ANTI-CALCULUS ORAL COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2016-01-14 WO claimed
EP-1998743-B1 Oral care compositions providing enhanced whitening and stain prevention PROCTER & GAMBLE (US) 2013-06-26 EP claimed
EP-1998743-A1 ORAL CARE COMPOSITIONS PROVIDING ENHANCED WHITENING AND STAIN PREVENTION The Procter and Gamble Company (US) 2008-12-10 EP claimed
EP-1962787-A2 ORAL CARE COMPOSITIONS COMPRISING ZINC AND PHYTATE The Procter and Gamble Company (US) 2008-09-03 EP claimed
US-20080138298-A1 Oral care compositions comprising zinc and phytate THE PROCTER & GAMBLE COMPANY 2008-06-12 US claimed
WO-2007111616-A1 ORAL CARE COMPOSITIONS PROVIDING ENHANCED WHITENING AND STAIN PREVENTION THE PROCTER & GAMBLE COMPANY (US) 2007-10-04 WO claimed
WO-2007076001-A2 ORAL CARE COMPOSITIONS COMPRISING ZINC AND PHYTATE THE PROCTER & GAMBLE COMPANY (US) 2007-07-05 WO claimed
US-20060171907-A1 Oral care compositions providing enhanced whitening and stain prevention THE PROCTER & GAMBLE COMPANY 2006-08-03 US claimed
EP-0616520-B1 PHYTATE-ANTIMICROBIAL COMPOSITIONS IN ORAL CARE PRODUCTS DOW CHEMICAL CO (US) 1996-05-29 EP claimed
EP-0616519-A1 ORAL COMPOSITIONS FOR SUPPRESSING MOUTH ODORS THE DOW CHEMICAL COMPANY (US) 1994-09-28 EP claimed
EP-0616520-A1 PHYTATE-ANTIMICROBIAL COMPOSITIONS IN ORAL CARE PRODUCTS. DOW CHEMICAL CO (US) 1994-09-28 EP claimed
US-5300289-A Cationic microbiocide and compatibilizer THE DOW CHEMICAL COMPANY (US) 1994-04-05 US claimed
US-5286479-A Copper salt; phytic acid; cationic antimicrobial compound; compatibilizing agent to enhance retention to hydroxyapatite surface THE DOW CHEMICAL COMPANY (US) 1994-02-15 US claimed
WO-1993011739-A1 ORAL COMPOSITIONS FOR SUPPRESSING MOUTH ODORS THE DOW CHEMICAL COMPANY (US) 1993-06-24 WO claimed
WO-1993011740-A1 PHYTATE-ANTIMICROBIAL COMPOSITIONS IN ORAL CARE PRODUCTS THE DOW CHEMICAL COMPANY (US) 1993-06-24 WO claimed
US-4873355-A Process for regioselectively preparing phosphorylated inositols and other cyclitols E. I. DU PONT DE NEMOURS AND COMPANY (US) 1989-10-10 US claimed
EP-4392142-A1 ORAL CARE COMPOSITIONS Colgate-Palmolive Company (US) 2024-07-03 EP disclosed
US-11998625-B2 Oral care compositions COLGATE-PALMOLIVE COMPANY (US) 2024-06-04 US disclosed
WO-2024112722-A1 ORAL CARE COMPOSITIONS COLGATE-PALMOLIVE COMPANY (US) 2024-05-30 WO disclosed
US-20240173226-A1 Oral Care Compositions COLGATE-PALMOLIVE COMPANY (US) 2024-05-30 US disclosed
EP-4370670-A1 PHYTASE VARIANTS WITH IMPROVED STABILITY AND IP4 ACTIVITY AB Enzymes Oy (FI) 2024-05-22 EP disclosed
EP-4370667-A1 PHYTASE VARIANTS AB Enzymes Oy (FI) 2024-05-22 EP disclosed
EP-4370669-A1 PHYTASE VARIANTS AB Enzymes Oy (FI) 2024-05-22 EP disclosed
US-20240100074-A1 Clinical Dosing Schedule of Inositol Phosphate Oligo(Ethylene Glycol) Compounds VIFOR (INTERNATIONAL) AG (CH) 2024-03-28 US disclosed
US-20240041722-A1 Oral Care Compositions COLGATE-PALMOLIVE COMPANY (US) 2024-02-08 US disclosed
US-20240000811-A1 INOSITOL HEXAKISPHOSPHATE ANALOGUES FOR TREATMENT OF CALCIFICATION ASSOCIATED KIDNEY DISEASES VIFOR (INTERNATIONAL) AG (CH) 2024-01-04 US disclosed
US-11849740-B2 Nutritional composition SOCIETE DES PRODUITS NESTLE S.A. (CH) 2023-12-26 US disclosed
EP-4284384-A1 CLINICAL DOSING SCHEDULE OF INOSITOL PHOSPHATE OLIGO(ETHYLENE GLYCOL) COMPOUNDS Vifor (International) AG (CH) 2023-12-06 EP disclosed
EP-3474812-B1 ORAL CARE COMPOSITIONS COLGATE PALMOLIVE CO (US) 2023-11-29 EP disclosed
US-11826452-B2 Reduction of tooth staining derived from cationic antimicrobials THE PROCTER & GAMBLE COMPANY (US) 2023-11-28 US disclosed
US-20230363991-A1 Oral Care Compositions COLGATE-PALMOLIVE COMPANY (US) 2023-11-16 US disclosed
US-11806417-B2 Oral care compositions COLGATE-PALMOLIVE COMPANY (US) 2023-11-07 US disclosed
US-11806418-B2 Oral care compositions COLGATE-PALMOLIVE COMPANY (US) 2023-11-07 US disclosed
US-11779526-B2 Oral care compositions COLGATE-PALMOLIVE COMPANY (US) 2023-10-10 US disclosed
EP-3541351-B1 ORAL CARE COMPOSITIONS COLGATE PALMOLIVE CO (US) 2023-10-04 EP disclosed
EP-4247388-A1 INOSITOL HEXAKISPHOSPHATE ANALOGUES FOR TREATMENT OF CALCIFICATION ASSOCIATED KIDNEY DISEASES VIFOR (INTERNATIONAL) AG (CH) 2023-09-27 EP disclosed
EP-4241757-A2 ORAL CARE COMPOSITIONS Colgate-Palmolive Company (US) 2023-09-13 EP disclosed
US-11752075-B2 Oral care compositions COLGATE-PALMOLIVE COMPANY (US) 2023-09-12 US disclosed
EP-3386467-B1 ORAL CARE COMPOSITIONS AND THEIR USE IN TREATING DENTAL EROSION COLGATE PALMOLIVE CO (US) 2023-08-30 EP disclosed
EP-4218710-A1 ORAL CARE COMPOSITIONS Colgate-Palmolive Company (US) 2023-08-02 EP disclosed
EP-4203900-A1 ORAL CARE COMPOSITIONS Colgate-Palmolive Company (US) 2023-07-05 EP disclosed
US-20230201099-A1 Oral Care Compositions KENVUE BRANDS LLC 2023-06-29 US disclosed
US-20230201098-A1 Oral Care Compositions KENVUE BRANDS LLC 2023-06-29 US disclosed
EP-4199887-A1 ORAL CARE COMPOSITIONS Colgate-Palmolive Company (US) 2023-06-28 EP disclosed
CN-116218723-A Inositol hexaphosphate-protein complex degrading bacterium and application thereof 江苏南资环保科技有限公司 2023-06-06 CN disclosed
EP-3541350-B1 ORAL CARE COMPOSITIONS COLGATE PALMOLIVE CO (US) 2023-05-24 EP disclosed
EP-3344217-B1 ORAL CARE COMPOSITIONS COLGATE PALMOLIVE CO (US) 2023-05-24 EP disclosed
EP-3534870-B1 ORAL CARE COMPOSITIONS COLGATE PALMOLIVE CO (US) 2023-05-17 EP disclosed
WO-2023076406-A1 ORAL CARE COMPOSITIONS COLGATE-PALMOLIVE COMPANY (US) 2023-05-04 WO disclosed
US-20230138092-A1 Oral Care Compositions COLGATE-PALMOLIVE COMPANY (US) 2023-05-04 US disclosed
EP-2346475-B2 PERSONAL CARE COMPOSITIONS PROVIDING ENHANCED COOLING SENSATION PROCTER & GAMBLE (US) 2023-04-19 EP disclosed
US-11590163-B2 Iron-fortified food composition SOCIETE DES PRODUITS NESTLE S.A. (CH) 2023-02-28 US disclosed
US-20230034301-A1 NUTRITIONAL COMPOSITION SOCIETE DES PRODUITS NESTLE S.A. (CH) 2023-02-02 US disclosed
WO-2023285736-A1 PHYTASE VARIANTS AB ENZYMES OY (FI) 2023-01-19 WO disclosed
WO-2023285735-A1 PHYTASE VARIANTS AB ENZYMES OY (FI) 2023-01-19 WO disclosed
WO-2023285737-A1 PHYTASE VARIANTS WITH IMPROVED STABILITY AND IP4 ACTIVITY AB ENZYMES OY (FI) 2023-01-19 WO disclosed
EP-4119658-A1 PHYTASE VARIANTS AB Enzymes Oy (FI) 2023-01-18 EP disclosed
EP-4119660-A1 PHYTASE VARIANTS AB Enzymes Oy (FI) 2023-01-18 EP disclosed
EP-4119661-A1 PHYTASE VARIANTS WITH IMPROVED STABILITY AND IP4 ACTIVITY AB Enzymes Oy (FI) 2023-01-18 EP disclosed
US-20220401321-A1 Oral Care Compositions COLGATE-PALMOLIVE COMPANY (US) 2022-12-22 US disclosed
US-20220387273-A1 Oral Care Compositions COLGATE-PALMOLIVE COMPANY (US) 2022-12-08 US disclosed
WO-2022251228-A1 ORAL CARE COMPOSITIONS COLGATE-PALMOLIVE COMPANY (US) 2022-12-01 WO disclosed
US-20220331211-A1 Oral Care Compositions COLGATE-PALMOLIVE COMPANY (US) 2022-10-20 US disclosed
EP-3659674-B1 ORAL CARE COMPOSITIONS AND METHODS OF USING THE COMPOSITIONS COLGATE PALMOLIVE CO (US) 2022-08-17 EP disclosed
US-20220192944-A1 Oral Care Compositions and Methods of Using the Compositions COLGATE-PALMOLIVE COMPANY (US) 2022-06-23 US disclosed
WO-2022106657-A1 INOSITOL HEXAKISPHOSPHATE ANALOGUES FOR TREATMENT OF CALCIFICATION ASSOCIATED KIDNEY DISEASES INOSITEC AG (CH) 2022-05-27 WO disclosed
US-11337903-B2 Oral care compositions COLGATE-PALMOLIVE COMPANY (US) 2022-05-24 US disclosed
US-20220133608-A1 Oral Care Compositions COLGATE-PALMOLIVE COMPANY (US) 2022-05-05 US disclosed
US-20220125694-A1 Oral Care Compositions COLGATE-PALMOLIVE COMPANY (US) 2022-04-28 US disclosed
US-11253449-B2 Oral care compositions COLGATE-PALMOLIVE COMPANY (US) 2022-02-22 US disclosed
US-11253451-B2 Reduction of tooth staining derived from cationic antibacterials THE PROCTER & GAMBLE COMPANY (US) 2022-02-22 US disclosed
US-20220047484-A1 Reduction Of Tooth Staining Derived From Cationic Antimicrobials PROCTER & GAMBLE (US) 2022-02-17 US disclosed
US-20220031593-A1 Oral Care Compositions COLGATE-PALMOLIVE COMPANY (US) 2022-02-03 US disclosed
US-11234912-B2 Oral care compositions COLGATE-PALMOLIVE COMPANY (US) 2022-02-01 US disclosed
US-20220016161-A1 IRON-FORTIFIED FOOD COMPOSITION SOCIETE DES PRODUITS NESTLE S.A. (CH) 2022-01-20 US disclosed
EP-3541346-B1 ORAL CARE COMPOSITIONS COLGATE PALMOLIVE CO (US) 2021-12-22 EP disclosed
US-11191709-B2 Reduction of tooth staining derived from cationic antimicrobials THE PROCTER & GAMBLE COMPANY (US) 2021-12-07 US disclosed
US-11179308-B2 Oral care compositions COLGATE-PALMOLIVE COMPANY (US) 2021-11-23 US disclosed
US-11160828-B2 Iron-fortified food composition SOCIETE DES PRODUITS NESTLE S.A. (CH) 2021-11-02 US disclosed
EP-3261608-B9 COMPOSITIONS COMPRISING COMBINATIONS OF ORGANIC ACIDS JOHNSON & JOHNSON CONSUMER INC (US) 2021-10-27 EP disclosed
EP-3883529-A1 ORAL CARE COMPOSITIONS Colgate-Palmolive Company (US) 2021-09-29 EP disclosed
EP-3582628-B1 IRON-FORTIFIED FOOD COMPOSITION NESTLE SA (CH) 2021-09-15 EP disclosed
US-20210205189-A1 Oral Care Compositions COLGATE-PALMOLIVE COMPANY (US) 2021-07-08 US disclosed
EP-3538056-B1 ORAL CARE COMPOSITIONS COLGATE PALMOLIVE CO (US) 2021-06-23 EP disclosed
EP-3578056-B1 NUTRITIONAL COMPOSITION COMPRISING A LENTIL PRODUCT NESTLE SA (CH) 2021-05-05 EP disclosed
US-10980720-B2 Oral care compositions COLGATE-PALMOLIVE COMPANY (US) 2021-04-20 US disclosed
US-20210106035-A1 NUTRITIONAL COMPOSITION NESTLE SA (CH) 2021-04-15 US disclosed
EP-3801052-A1 NUTRITIONAL COMPOSITION COMPRISING A LENTIL PRODUCT Société des Produits Nestlé S.A. (CH) 2021-04-14 EP disclosed
EP-3261609-B1 COMPOSITIONS COMPRISING SUCCINIC ACID AND ACONITIC ACID JOHNSON & JOHNSON CONSUMER INC (US) 2021-04-07 EP disclosed
EP-3344053-B1 IRON-FORTIFIED FOOD COMPOSITION NESTLE SA (CH) 2021-03-31 EP disclosed
EP-3355849-B1 ORAL CARE COMPOSITIONS AND METHODS OF USING THE COMPOSITIONS COLGATE PALMOLIVE CO (US) 2021-03-10 EP disclosed
EP-3261608-B1 COMPOSITIONS COMPRISING COMBINATIONS OF ORGANIC ACIDS JOHNSON & JOHNSON CONSUMER INC (US) 2021-02-17 EP disclosed
US-20200368127-A1 Oral Care Compositions COLGATE-PALMOLIVE COMPANY (US) 2020-11-26 US disclosed
US-20200368126-A1 Oral Care Compositions COLGATE-PALMOLIVE COMPANY (US) 2020-11-26 US disclosed
US-20200337972-A1 Reduction Of Tooth Staining Derived From Cationic Antimicrobials THE PROCTER & GAMBLE COMPANY 2020-10-29 US disclosed
EP-3720416-A1 ORAL CARE COMPOSITION Johnson & Johnson Consumer Inc. (US) 2020-10-14 EP disclosed
EP-3720563-A1 ORAL CARE COMPOSITIONS Johnson & Johnson Consumer Inc. (US) 2020-10-14 EP disclosed
US-20200297597-A1 Oral Care Compositions COLGATE-PALMOLIVE COMPANY (US) 2020-09-24 US disclosed
US-10772810-B2 Oral care compositions COLGATE-PALMOLIVE COMPANY (US) 2020-09-15 US disclosed
US-10772809-B2 Oral care compositions COLGATE-PALMOLIVE COMPANY (US) 2020-09-15 US disclosed
US-20200230041-A1 Oral Care Compositions COLGATE-PALMOLIVE COMPANY (US) 2020-07-23 US disclosed
US-10709648-B2 Oral care compositions COLGATE-PALMOLIVE COMPANY (US) 2020-07-14 US disclosed
US-20200206109-A1 Oral Care Compositions COLGATE-PALMOLIVE COMPANY (US) 2020-07-02 US disclosed
WO-2020139669-A1 ORAL CARE COMPOSITIONS COLGATE-PALMOLIVE COMPANY (US) 2020-07-02 WO disclosed
US-20200170902-A1 REDUCTION OF TOOTH STAINING DERIVED FROM CATIONIC ANTIBACTERIALS PROCTER & GAMBLE (US) 2020-06-04 US disclosed
EP-3659674-A1 ORAL CARE COMPOSITIONS AND METHODS OF USING THE COMPOSITIONS Colgate-Palmolive Company (US) 2020-06-03 EP disclosed
US-20200155427-A1 Oral Care Compositions COLGATE-PALMOLIVE COMPANY (US) 2020-05-21 US disclosed
US-10646426-B2 Oral care compositions COLGATE-PALMOLIVE COMPANY (US) 2020-05-12 US disclosed
US-20200121572-A1 Oral Care Compositions COLGATE-PALMOLIVE COMPANY (US) 2020-04-23 US disclosed
US-20200113794-A1 Oral Care Compositions COLGATE-PALMOLIVE COMPANY (US) 2020-04-16 US disclosed
EP-3349860-B1 ORAL CARE COMPOSITIONS COLGATE PALMOLIVE CO (US) 2020-04-15 EP disclosed
US-10617140-B2 Iron-fortified food composition SOCIETE DES PRODUITS NESTLE S.A. (CH) 2020-04-14 US disclosed
US-10596086-B2 Reduction of tooth staining derived from cationic antibacterials THE PROCTER & GAMBLE COMPANY (US) 2020-03-24 US disclosed
US-10576029-B2 Oral care compositions COLGATE-PALMOLIVE COMPANY (US) 2020-03-03 US disclosed
EP-3541346-A1 ORAL CARE COMPOSITIONS Colgate-Palmolive Company (US) 2019-09-25 EP disclosed
EP-3541351-A1 ORAL CARE COMPOSITIONS Colgate-Palmolive Company (US) 2019-09-25 EP disclosed
EP-3541350-A1 ORAL CARE COMPOSITIONS Colgate-Palmolive Company (US) 2019-09-25 EP disclosed
EP-3538057-A1 ORAL CARE COMPOSITIONS Colgate-Palmolive Company (US) 2019-09-18 EP disclosed
EP-3538056-A1 ORAL CARE COMPOSITIONS Colgate-Palmolive Company (US) 2019-09-18 EP disclosed
EP-3534870-A1 ORAL CARE COMPOSITIONS Colgate-Palmolive Company (US) 2019-09-11 EP disclosed
US-10406087-B2 Oral care compositions COLGATE-PALMOLIVE COMPANY (US) 2019-09-10 US disclosed
US-20190224089-A1 Oral Care Compositions COLGATE-PALMOLIVE COMPANY (US) 2019-07-25 US disclosed
US-20190192395-A1 Oral Care Compositions COLGATE-PALMOLIVE COMPANY (US) 2019-06-27 US disclosed
US-20190192394-A1 Oral Care Compositions and Methods of Using the Compositions COLGATE-PALMOLIVE COMPANY (US) 2019-06-27 US disclosed
WO-2019112869-A1 ORAL CARE COMPOSITIONS JOHNSON & JOHNSON CONSUMER INC. (US) 2019-06-13 WO disclosed
US-20190175487-A1 Oral Care Compositions JOHNSON & JOHNSON CONSUMER INC. 2019-06-13 US disclosed
US-20190175486-A1 Oral Care Compositions JOHNSON & JOHNSON CONSUMER INC. 2019-06-13 US disclosed
WO-2019112868-A1 ORAL CARE COMPOSITION JOHNSON & JOHNSON CONSUMER INC. (US) 2019-06-13 WO disclosed
US-10285919-B2 Oral care compositions COLGATE-PALMOLIVE COMPANY (US) 2019-05-14 US disclosed
US-10278906-B2 Oral care compositions COLGATE-PALMOLIVE COMPANY (US) 2019-05-07 US disclosed
EP-3166572-B1 ANTI-CALCULUS ORAL COMPOSITIONS PROCTER & GAMBLE (US) 2019-05-01 EP disclosed
US-20190117542-A1 Oral Care Compositions COLGATE-PALMOLIVE COMPANY (US) 2019-04-25 US disclosed
US-20190110965-A1 Oral Care Compositions COLGATE-PALMOLIVE COMPANY (US) 2019-04-18 US disclosed
US-10258551-B2 Oral care compositions and methods of using the compositions COLGATE-PALMOLIVE COMPANY (US) 2019-04-16 US disclosed
US-20190105252-A1 Oral Care Compositions COLGATE-PALMOLIVE COMPANY (US) 2019-04-11 US disclosed
US-10206865-B2 Oral compositions containing polymethylsilsesquioxane particles THE PROCTER & GAMBLE COMPANY (US) 2019-02-19 US disclosed
US-10195128-B2 Oral care compositions COLGATE-PALMOLIVE COMPANY (US) 2019-02-05 US disclosed
US-10179098-B2 Oral care compositions COLGATE-PALMOLIVE COMPANY (US) 2019-01-15 US disclosed
US-10172770-B2 Oral care compositions COLGATE-PALMOLIVE COMPANY (US) 2019-01-08 US disclosed
EP-2293850-B1 COMPOSITIONS AND METHODS FOR IMPROVING OVERALL TOOTH HEALTH AND APPEARANCE PROCTER & GAMBLE (US) 2019-01-02 EP disclosed
US-10149803-B2 Anti-calculus oral compositions THE PROCTER & GAMBLE COMPANY (US) 2018-12-11 US disclosed
US-10123953-B2 Reduction of tooth staining derived from cationic antimicrobials THE PROCTER & GAMBLE COMPANY (US) 2018-11-13 US disclosed
US-20180280263-A1 Oral Care Compositions and Methods of Using the Compositions COLGATE-PALMOLIVE COMPANY (US) 2018-10-04 US disclosed
EP-2553444-B1 WHOLE MOUTH MALODOR CONTROL BY A COMBINATION OF ANTIBACTERIAL AND DEODORIZING AGENTS PROCTER & GAMBLE (US) 2018-09-26 EP disclosed
US-20180249752-A1 IRON-FORTIFIED FOOD COMPOSITION Société des Produits Nestlé S.A. (CH) 2018-09-06 US disclosed
WO-2018149846-A1 IRON-FORTIFIED FOOD COMPOSITION NESTEC S.A. (CH) 2018-08-23 WO disclosed
EP-2863875-B1 MOUTH RINSE EMULSIONS PROCTER & GAMBLE (US) 2018-08-22 EP disclosed
EP-3349860-A1 ORAL CARE COMPOSITIONS AND METHODS OF USING THE COMPOSITIONS Colgate-Palmolive Company (US) 2018-07-25 EP disclosed
EP-3344053-A1 IRON-FORTIFIED FOOD COMPOSITION Nestec S.A. (CH) 2018-07-11 EP disclosed
EP-3344217-A1 ORAL CARE COMPOSITIONS Colgate-Palmolive Company (US) 2018-07-11 EP disclosed
WO-2018118140-A1 ORAL CARE COMPOSITIONS COLGATE-PALMOLIVE COMPANY (US) 2018-06-28 WO disclosed
WO-2018118139-A1 ORAL CARE COMPOSITIONS COLGATE-PALMOLIVE COMPANY (US) 2018-06-28 WO disclosed
WO-2018118142-A1 ORAL CARE COMPOSITIONS COLGATE-PALMOLIVE COMPANY (US) 2018-06-28 WO disclosed
WO-2018118138-A1 ORAL CARE COMPOSITIONS COLGATE-PALMOLIVE COMPANY (US) 2018-06-28 WO disclosed
WO-2018118145-A1 ORAL CARE COMPOSITIONS COLGATE-PALMOLIVE COMPANY (US) 2018-06-28 WO disclosed
WO-2018118141-A1 ORAL CARE COMPOSITIONS COLGATE-PALMOLIVE COMPANY (US) 2018-06-28 WO disclosed
US-20180168962-A1 Oral Care Compositions COLGATE-PALMOLIVE COMPANY (US) 2018-06-21 US disclosed
US-20180168964-A1 Oral Care Compositions COLGATE-PALMOLIVE COMPANY (US) 2018-06-21 US disclosed
US-20180168977-A1 Oral Care Compositions COLGATE-PALMOLIVE COMPANY (US) 2018-06-21 US disclosed
US-20180168978-A1 Oral Care Compositions COLGATE-PALMOLIVE COMPANY (US) 2018-06-21 US disclosed
US-20180168961-A1 Oral Care Compositions COLGATE-PALMOLIVE COMPANY (US) 2018-06-21 US disclosed
US-20180168963-A1 Oral Care Compositions COLGATE-PALMOLIVE COMPANY (US) 2018-06-21 US disclosed
EP-2863863-B1 REDUCTION OF TOOTH STAINING DERIVED FROM CATIONIC ANTIMICROBIALS PROCTER & GAMBLE (US) 2018-05-30 EP disclosed
US-20180140518-A1 Heat Treated Precipitated Silica PROCTER & GAMBLE (US) 2018-05-24 US disclosed
US-9918915-B2 Personal care compositions providing enhanced cooling sensation THE PROCTER & GAMBLE COMPANY (US) 2018-03-20 US disclosed
US-9918914-B2 Heat treated precipitated silica THE PROCTER & GAMBLE COMPANY (US) 2018-03-20 US disclosed
US-9896714-B2 Method of detecting phytase activity or protease activity DUPONT NUTRITION BIOSCIENCES APS (DK) 2018-02-20 US disclosed
US-9872491-B2 Compositions comprising combinations of organic acids JOHNSON & JOHNSON CONSUMER INC. (US) 2018-01-23 US disclosed
EP-3261608-A1 COMPOSITIONS COMPRISING COMBINATIONS OF ORGANIC ACIDS Johnson & Johnson Consumer Inc. (US) 2018-01-03 EP disclosed
EP-3261609-A1 COMPOSITIONS COMPRISING COMBINATIONS OF ORGANIC ACIDS Johnson & Johnson Consumer Inc. (US) 2018-01-03 EP disclosed
EP-3261610-A1 COMPOSITIONS COMPRISING COMBINATIONS OF ORGANIC ACIDS Johnson & Johnson Consumer Inc. (US) 2018-01-03 EP disclosed
US-20170367947-A1 Oral Care Compositions COLGATE-PALMOLIVE COMPANY (US) 2017-12-28 US disclosed
US-20170367946-A1 Oral Care Compositions and Methods of Using the Compositions COLGATE-PALMOLIVE COMPANY (US) 2017-12-28 US disclosed
WO-2017223311-A1 ORAL CARE COMPOSITIONS COLGATE-PALMOLIVE COMPANY (US) 2017-12-28 WO disclosed
US-20170367949-A1 Oral Care Compositions COLGATE-PALMOLIVE COMPANY (US) 2017-12-28 US disclosed
EP-3013309-B1 A STAIN-PROOF ORAL CARE COMPOSITION PROCTER & GAMBLE (US) 2017-12-27 EP disclosed
US-20170281490-A1 REDUCTION OF TOOTH STAINING DERIVED FROM CATIONIC ANTIBACTERIALS PROCTER & GAMBLE (US) 2017-10-05 US disclosed
US-20170216192-A1 Oral Compositions Containing Polymethylsilsesquioxane Particles PROCTER & GAMBLE (US) 2017-08-03 US disclosed
EP-3166572-A1 ANTI-CALCULUS ORAL COMPOSITIONS The Procter and Gamble Company (US) 2017-05-17 EP disclosed
US-9649273-B2 Oral compositions containing polymethylsilsesquioxane particles THE PROCTER & GAMBLE COMPANY (US) 2017-05-16 US disclosed
WO-2017062021-A1 ORAL CARE COMPOSITIONS AND METHODS OF USING THE COMPOSITIONS COLGATE-PALMOLIVE COMPANY (US) 2017-04-13 WO disclosed
EP-2914236-B1 HEAT TREATED PRECIPITATED SILICA PROCTER & GAMBLE (US) 2017-03-29 EP disclosed
EP-2346475-B1 PERSONAL CARE COMPOSITIONS PROVIDING ENHANCED COOLING SENSATION PROCTER & GAMBLE (US) 2017-03-15 EP disclosed
WO-2017037200-A1 IRON-FORTIFIED FOOD COMPOSITION NESTEC S.A. (CH) 2017-03-09 WO disclosed
US-9566226-B2 Oral compositions containing polymethylsilsesquioxane particles THE PROCTER & GAMBLE COMPANY (US) 2017-02-14 US disclosed
EP-3127583-A1 A METHOD OF DEMONSTRATING STAIN-PROOF EFFICACY OF AN ORAL CARE COMPOSITION The Procter and Gamble Company (US) 2017-02-08 EP disclosed
US-9549887-B2 Oral compositions containing polyorganosilsesquioxane particles THE PROCTER & GAMBLE COMPANY (US) 2017-01-24 US disclosed
EP-2349191-B2 ORAL CARE COMPOSITIONS COMPRISING SPHERICAL FUSED SILICA PROCTER & GAMBLE (US) 2016-12-21 EP disclosed
WO-2016138217-A1 COMPOSITIONS COMPRISING COMBINATIONS OF ORGANIC ACIDS JOHNSON & JOHNSON CONSUMER INC. (US) 2016-09-01 WO disclosed
WO-2016138211-A1 COMPOSITIONS COMPRISING COMBINATIONS OF ORGANIC ACIDS JOHNSON & JOHNSON CONSUMER INC. (US) 2016-09-01 WO disclosed
US-20160250114-A1 Heat Treated Precipitated Silica PROCTER & GAMBLE (US) 2016-09-01 US disclosed
US-20160249612-A1 COMPOSITIONS COMPRISING COMBINATIONS OF ORGANIC ACIDS KENVUE BRANDS LLC 2016-09-01 US disclosed
WO-2016138214-A1 COMPOSITIONS COMPRISING COMBINATIONS OF ORGANIC ACIDS JOHNSON & JOHNSON CONSUMER INC. (US) 2016-09-01 WO disclosed
EP-2516670-B1 Method DUPONT NUTRITION BIOSCI APS (DK) 2016-08-24 EP disclosed
EP-3013309-A1 A STAIN-PROOF ORAL CARE COMPOSITION The Procter & Gamble Company (US) 2016-05-04 EP disclosed
US-9326925-B1 Compositions comprising combinations of organic acids JOHNSON & JOHNSON CONSUMER INC. (US) 2016-05-03 US disclosed
US-9326924-B1 Compositions comprising combinations of organic acids JOHNSON & JOHNSON CONSUMER INC. (US) 2016-05-03 US disclosed
EP-2365844-B1 ANTIBACTERIAL ORAL CARE COMPOSITIONS WITH FUSED SILICA PROCTER & GAMBLE (US) 2016-03-23 EP disclosed
EP-2995351-A1 ANTI-SENSITIVITY ORAL CARE COMPOSITIONS WITH FUSED SILICA The Procter and Gamble Company (US) 2016-03-16 EP disclosed
EP-2983635-A1 ORAL CARE COMPOSITIONS CONTAINING POLYORGANOSILSESQUIOXANE PARTICLES The Procter & Gamble Company (US) 2016-02-17 EP disclosed
EP-2983795-A1 ORAL CARE COMPOSITIONS CONTAINING POLYORGANOSILSESQUIOXANE PARTICLES The Procter & Gamble Company (US) 2016-02-17 EP disclosed
EP-2983793-A1 ORAL CARE COMPOSITIONS CONTAINING POLYORGANOSILSESQUIOXANE PARTICLES The Procter & Gamble Company (US) 2016-02-17 EP disclosed
EP-2983794-A1 ORAL CARE COMPOSITIONS CONTAINING POLYORGANOSILSESQUIOXANE PARTICLES The Procter & Gamble Company (US) 2016-02-17 EP disclosed
EP-2983796-A1 ORAL CARE COMPOSITIONS CONTAINING POLYORGANOSILSESQUIOXANE PARTICLES The Procter & Gamble Company (US) 2016-02-17 EP disclosed
EP-2983637-A1 ORAL CARE COMPOSITIONS CONTAINING POLYORGANOSILSESQUIOXANE PARTICLES The Procter & Gamble Company (US) 2016-02-17 EP disclosed
US-20160038394-A1 Oral Compositions Containing Polyorganosilsesquioxane Particles PROCTER & GAMBLE (US) 2016-02-11 US disclosed
US-20160008238-A1 Anti-Calculus Oral Compositions THE PROCTER & GAMBLE COMPANY 2016-01-14 US disclosed
WO-2016004597-A1 ANTI-CALCULUS ORAL COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2016-01-14 WO disclosed
EP-1998738-B1 ORAL CARE COMPOSITIONS HAVING IMPROVED CONSUMER AESTHETICS AND TASTE PROCTER & GAMBLE (US) 2016-01-13 EP disclosed
EP-2038012-B1 FLAVOR OILS WITH REDUCED SULFUR CONTENT AND USE IN ORAL CARE COMPOSITIONS PROCTER & GAMBLE (US) 2015-12-23 EP disclosed
US-9192563-B2 Oral care compositions containing polyorganosilsesquioxane particles THE PROCTER & GAMBLE COMPANY (US) 2015-11-24 US disclosed
US-9186306-B2 Oral compositions containing polymethylsilsesquioxane particles THE PROCTER & GAMBLE COMPANY (US) 2015-11-17 US disclosed
EP-2349489-B1 LOW PH ORAL CARE COMPOSITIONS WITH FUSED SILICA AND A FLUORIDE SOURCE PROCTER & GAMBLE (US) 2015-11-11 EP disclosed
EP-2037866-B1 FLAVORS FOR ORAL COMPOSITIONS PROCTER & GAMBLE (US) 2015-11-11 EP disclosed
EP-2349488-B1 ORAL CARE COMPOSITIONS WITH FUSED SILICA PROCTER & GAMBLE (US) 2015-10-28 EP disclosed
US-9161895-B1 Compositions and methods for improving overall tooth health and appearance THE PROCTER & GAMBLE COMPANY (US) 2015-10-20 US disclosed
US-20150290115-A1 Oral Compositions Containing Polymethylsilsesquioxane Particles PROCTER & GAMBLE (US) 2015-10-15 US disclosed
US-9155769-B2 Flavor oils with reduced dimethyl sulfoxide content and use in oral compositions THE PROCTER & GAMBLE CO (US) 2015-10-13 US disclosed
EP-2349487-B1 ORAL CARE COMPOSITIONS CONTAINING GEL NETWORKS AND FUSED SILICA PROCTER & GAMBLE (US) 2015-09-30 EP disclosed
US-9144578-B2 Fixed-dose association of phytate and zinc UNIVERSITAT DE LES ILLES BALEARS (ES) 2015-09-29 US disclosed
US-9139731-B2 Compositions and methods for improving overall tooth health and appearance THE PROCTER & GAMBLE COMPANY (US) 2015-09-22 US disclosed
EP-2914236-A2 HEAT TREATED PRECIPITATED SILICA The Procter & Gamble Company (US) 2015-09-09 EP disclosed
US-9114095-B2 Oral care particle compositions comprising polyorganosilsesquioxane and an oxidizing agent THE PROCTER & GAMBLE COMPANY (US) 2015-08-25 US disclosed
EP-2863875-A2 MOUTH RINSE EMULSIONS The Procter & Gamble Company (US) 2015-04-29 EP disclosed
EP-2863863-A1 REDUCTION OF TOOTH STAINING DERIVED FROM CATIONIC ANTIMICROBIALS The Procter & Gamble Company (US) 2015-04-29 EP disclosed
US-9017647-B2 Oral compositions containing polyorganosilsesquioxane particles THE PROCTER & GAMBLE COMPANY (US) 2015-04-28 US disclosed
US-9011825-B2 Oral care compositions containing polyorganosilsesquioxane particles THE PROCTER & GAMBLE COMPANY (US) 2015-04-21 US disclosed
EP-2318356-B1 SYNTHESIS OF CYCLOHEXANE DERIVATIVES USEFUL AS SENSATES IN CONSUMER PRODUCTS PROCTER & GAMBLE (US) 2015-03-11 EP disclosed
WO-2014205631-A1 A STAIN-PROOF ORAL CARE COMPOSITION THE PROCTER & GAMBLE COMPANY (US) 2014-12-31 WO disclosed
US-20140377194-A1 Stain-Proof Oral Care Composition THE PROCTER & GAMBLE COMPANY 2014-12-25 US disclosed
US-8865192-B2 Flavor oils with reduced sulfur content and use in oral care compositions THE PROCTER & GAMBLE CO (US) 2014-10-21 US disclosed
WO-2014169114-A1 ORAL CARE COMPOSITIONS CONTAINING POLYORGANOSILSESQUIOXANE PARTICLES THE PROCTER & GAMBLE COMPANY (US) 2014-10-16 WO disclosed
WO-2014169083-A1 ORAL CARE COMPOSITIONS CONTAINING POLYORGANOSILSESQUIOXANE PARTICLES THE PROCTER & GAMBLE COMPANY (US) 2014-10-16 WO disclosed
US-20140308324-A1 Oral Compositions Containing Polymethylsilsesquioxane Particles THE PROCTER & GAMBLE COMPANY (US) 2014-10-16 US disclosed
WO-2014169109-A1 ORAL CARE COMPOSITIONS CONTAINING POLYORGANOSILSESQUIOXANE PARTICLES THE PROCTER & GAMBLE COMPANY (US) 2014-10-16 WO disclosed
US-20140308322-A1 Oral Care Compositions Containing Polyorganosilsesquioxane Particles THE PROCTER & GAMBLE COMPANY (US) 2014-10-16 US disclosed
US-20140308323-A1 Oral Compositions Containing Polymethylsilsesquioxane Particles THE PROCTER & GAMBLE COMPANY (US) 2014-10-16 US disclosed
WO-2014169084-A1 ORAL CARE COMPOSITIONS CONTAINING POLYORGANOSILSESQUIOXANE PARTICLES THE PROCTER & GAMBLE COMPANY (US) 2014-10-16 WO disclosed
US-20140308321-A1 Oral Care Compositions Containing Polyorganosilsesquioxane Particles THE PROCTER & GAMBLE COMPANY (US) 2014-10-16 US disclosed
US-20140308320-A1 Oral Care Compositions Containing Polyorganosilsesquioxane Particles THE PROCTER & GAMBLE COMPANY (US) 2014-10-16 US disclosed
WO-2014169082-A1 ORAL CARE COMPOSITIONS CONTAINING POLYORGANOSILSESQUIOXANE PARTICLES THE PROCTER & GAMBLE COMPANY (US) 2014-10-16 WO disclosed
WO-2014169085-A1 ORAL CARE COMPOSITIONS CONTAINING POLYORGANOSILSESQUIOXANE PARTICLES THE PROCTER & GAMBLE COMPANY (US) 2014-10-16 WO disclosed
US-20140308355-A1 Oral Compositions Containing Polyorganosilsesquioxane Particles THE PROCTER & GAMBLE COMPANY (US) 2014-10-16 US disclosed
US-20140296134-A1 METHODS AND USES FOR METABOLIC PROFILING FOR CLOSTRIDIUM DIFFICILE INFECTION THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2014-10-02 US disclosed
EP-2776829-A1 METHODS AND USES FOR METABOLIC PROFILING FOR CLOSTRIDIUM DIFFICILE INFECTION The Board of Regents of The University of Texas System (US) 2014-09-17 EP disclosed
EP-2349491-B1 SENSITIVITY ORAL CARE COMPOSITIONS PROCTER & GAMBLE (US) 2014-08-06 EP disclosed
US-8795637-B2 Oral care compositions with fused silica THE PROCTER & GAMBLE COMPANY (US) 2014-08-05 US disclosed
US-20140186272-A1 SYNTHESIS OF CYCLOHEXANE DERIVATIVES USEFUL AS SENSATES IN CONSUMER PRODUCTS THE PROCTER & GAMBLE COMPANY (US) 2014-07-03 US disclosed
EP-2349490-B1 WHITENING COMPOSITION WITH FUSED SILICA PROCTER & GAMBLE (US) 2014-07-02 EP disclosed
US-8754259-B2 Synthesis of cyclohexane derivatives useful as sensates in consumer products THE PROCTER & GAMBLE COMPANY (US) 2014-06-17 US disclosed
WO-2014071284-A2 HEAT TREATED PRECIPITATED SILICA THE PROCTER & GAMBLE COMPANY (US) 2014-05-08 WO disclosed
US-20140127145-A1 Heat Treated Precipitated Silica THE PROCTER & GAMBLE COMPANY (US) 2014-05-08 US disclosed
US-20140056994-A1 Fixed-Dose Association of Phytate and Zinc UNIVERSITAT DE LES ILLES BALEARS (ES) 2014-02-27 US disclosed
WO-2013192463-A1 REDUCTION OF TOOTH STAINING DERIVED FROM CATIONIC ANTIMICROBIALS THE PROCTER & GAMBLE COMPANY (US) 2013-12-27 WO disclosed
WO-2013192382-A2 MOUTH RINSE EMULSIONS THE PROCTER & GAMBLE COMPANY (US) 2013-12-27 WO disclosed
US-20130344011-A1 Reduction Of Tooth Staining Derived From Cationic Antimicrobials THE PROCTER & GAMBLE COMPANY 2013-12-26 US disclosed
US-20130344120-A1 Mouth Rinse Emulsions THE PROCTER & GAMBLE COMPANY 2013-12-26 US disclosed
EP-2349492-B1 DENTIFRICE COMPOSITIONS WITH FUSED SILICA PROCTER & GAMBLE (US) 2013-12-25 EP disclosed
EP-2349190-B1 ORAL CARE COMPOSITIONS WITH IMPROVED AESTHETICS AND FUSED SILICA PROCTER & GAMBLE (US) 2013-11-06 EP disclosed
US-8551457-B2 Oral care compositions comprising spherical fused silica THE PROCTER & GAMBLE COMPANY (US) 2013-10-08 US disclosed
EP-2349180-B1 IMPROVED CLEANING ORAL CARE COMPOSITIONS PROCTER & GAMBLE (US) 2013-08-28 EP disclosed
US-20130216486-A1 SYNTHESIS OF CYCLOHEXANE DERIVATIVES USEFUL AS SENSATES IN CONSUMER PRODUCTS THE PROCTER & GAMBLE COMPANY (US) 2013-08-22 US disclosed
CN-103184199-A Inositol polyphosphate 2-kinase genes and uses thereof DOW AGROSCIENCES LLC 2013-07-03 CN disclosed
EP-1998743-B1 Oral care compositions providing enhanced whitening and stain prevention PROCTER & GAMBLE (US) 2013-06-26 EP disclosed
EP-2349191-B1 ORAL CARE COMPOSITIONS COMPRISING SPHERICAL FUSED SILICA PROCTER & GAMBLE (US) 2013-06-19 EP disclosed
EP-2595642-A2 COMPOSITIONS COMPRISING DERIVATIVES OF ESSENTIAL OIL COMPOUNDS AND USE IN PERSONAL CARE PRODUCTS The Procter and Gamble Company (US) 2013-05-29 EP disclosed
WO-2013070962-A1 METHODS AND USES FOR METABOLIC PROFILING FOR CLOSTRIDIUM DIFFICILE INFECTION THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2013-05-16 WO disclosed
US-8426643-B2 Synthesis of cyclohexane derivatives useful as sensates in consumer products THE PROCTER & GAMBLE COMPANY (US) 2013-04-23 US disclosed
CN-103045553-A Inositol polyphosphate 2-kinase and usage thereof DOW AGROSCIENCES LLC 2013-04-17 CN disclosed
CN-103045622-A Inositol polyphosphate 2-kinase genes and uses thereof DOW AGROSCIENCES LLC 2013-04-17 CN disclosed
CN-103039358-A Inositol polyphosphate 2-kinase genes and uses thereof DOW AGROSCIENCES LLC 2013-04-17 CN disclosed
CN-103045594-A Inositol polyphosphate 2-kinase genes and uses thereof DOW AGROSCIENCES LLC 2013-04-17 CN disclosed
US-8377908-B2 Fixed-dose association of phytate and zinc UNIVERSITAT DE LES ILLES BALEARS (ES) 2013-02-19 US disclosed
EP-2553444-A2 WHOLE MOUTH MALODOR CONTROL BY A COMBINATION OF ANTIBACTERIAL AND DEODORIZING AGENTS The Procter & Gamble Company (US) 2013-02-06 EP disclosed
EP-2054494-B1 FLAVOR OILS WITH REDUCED SULFUR CONTENT AND USE IN ORAL CARE COMPOSITIONS PROCTER & GAMBLE (US) 2013-01-09 EP disclosed
CN-101076587-B Inositol polyphosphate 2-kinase gene and use thereof DOW AGROSCIENCES LLC 2012-11-07 CN disclosed
EP-2516670-A1 METHOD DuPont Nutrition Biosciences ApS (DK) 2012-10-31 EP disclosed
US-8293216-B2 Cleaning oral care compositions THE PROCTER & GAMBLE COMPANY (US) 2012-10-23 US disclosed
US-20120264153-A1 METHOD OF DETECTING PHYTASE ACTIVITY OR PROTEASE ACTIVITY DANISCO A/S (DK) 2012-10-18 US disclosed
US-8277824-B2 Solubilization of cyclohexane-based carboxamide derivatives for use as sensates in consumer products THE PROCTER & GAMBLE COMPANY (US) 2012-10-02 US disclosed
US-20120219606-A1 Oral Care Compositions Comprising Spherical Fused Silica THE PROCTER & GAMBLE COMPANY 2012-08-30 US disclosed
US-8226932-B2 Prophy paste and weekly oral care compositions THE PROCTER & GAMBLE COMPANY (US) 2012-07-24 US disclosed
EP-2475431-A2 METHODS AND COMPOSITIONS FOR HYDROPHOBIC MODIFICATION OF ORAL CAVITY SURFACES The Procter & Gamble Company (US) 2012-07-18 EP disclosed
US-8221726-B2 Sensitivity oral care compositions THE PROCTER & GAMBLE COMPANY (US) 2012-07-17 US disclosed
US-8221723-B2 Oral care compositions with abrasive combinations THE PROCTER & GAMBLE COMPANY (US) 2012-07-17 US disclosed
US-8221725-B2 Oral care compositions comprising spherical fused silica THE PROCTER & GAMBLE COMPANY (US) 2012-07-17 US disclosed
US-8221722-B2 Antibacterial oral care compositions with fused silica THE PROCTER & GAMBLE COMPANY (US) 2012-07-17 US disclosed
US-8221724-B2 Mild oral care compositions THE PROCTER & GAMBLE COMPANY (US) 2012-07-17 US disclosed
US-8216552-B2 Oral care compositions containing gel networks and fused silica THE PROCTER & GAMBLE COMPANY (US) 2012-07-10 US disclosed
US-8216553-B2 Oral care compositions with improved aesthetics and fused silica THE PROCTER & GAMBLE COMPANY (US) 2012-07-10 US disclosed
US-8211409-B2 Whitening composition with fused silica THE PROCTER & GAMBLE COMPANY (US) 2012-07-03 US disclosed
US-8211408-B2 Low pH oral care compositions with fused silica THE PROCTOR & GAMBLE COMPANY (US) 2012-07-03 US disclosed
US-8211411-B2 Oral care compositions comprising fused silica THE PROCTER & GAMBLE COMPANY (US) 2012-07-03 US disclosed
US-8211410-B2 Oral care compositions with chelants and fused silica THE PROCTER & GAMBLE COMPANY (US) 2012-07-03 US disclosed
US-8211407-B2 Method of making oral care compositions with fused silica slurries THE PROCTER & GAMBLE COMPANY (US) 2012-07-03 US disclosed
US-8211406-B2 Oral care compositions with fused silica THE PROCTER & GAMBLE COMPANY (US) 2012-07-03 US disclosed
WO-2012012385-A2 COMPOSITIONS COMPRISING DERIVATIVES OF ESSENTIAL OIL COMPOUNDS AND USE IN PERSONAL CARE PRODUCTS THE PROCTER & GAMBLE COMPANY (US) 2012-01-26 WO disclosed
US-20120014883-A1 Compositions Comprising Derivatives Of Essential Oil Compounds And Use In Personal Care Products THE PROCTER & GAMBLE COMPANY 2012-01-19 US disclosed
WO-2011123601-A2 WHOLE MOUTH MALODOR CONTROL BY A COMBINATION OF ANTIBACTERIAL AND DEODORIZING AGENTS THE PROCTER & GAMBLE COMPANY (US) 2011-10-06 WO disclosed
US-20110239736-A1 Whole Mouth Malador Control By A Combination Of Antibacterial And Deodorizing Agents THE PROCTER & GAMBLE COMPANY 2011-10-06 US disclosed
EP-2365844-A2 ANTIBACTERIAL ORAL CARE COMPOSITIONS WITH FUSED SILICA The Procter & Gamble Company (US) 2011-09-21 EP disclosed
US-8007771-B2 Flavors for oral compositions THE PROCTER & GAMBLE COMPANY (US) 2011-08-30 US disclosed
EP-2349191-A1 ORAL CARE COMPOSITIONS COMPRISING SPHERICAL FUSED SILICA The Procter & Gamble Company (US) 2011-08-03 EP disclosed
EP-2349180-A1 IMPROVED CLEANING ORAL CARE COMPOSITIONS The Procter & Gamble Company (US) 2011-08-03 EP disclosed
EP-2349489-A2 LOW PH ORAL CARE COMPOSITIONS WITH FUSED SILICA AND A FLUORIDE SOURCE The Procter & Gamble Company (US) 2011-08-03 EP disclosed
EP-2349488-A2 ORAL CARE COMPOSITIONS WITH FUSED SILICA The Procter & Gamble Company (US) 2011-08-03 EP disclosed
EP-2349487-A2 ORAL CARE COMPOSITIONS CONTAINING GEL NETWORKS AND FUSED SILICA The Procter & Gamble Company (US) 2011-08-03 EP disclosed
EP-2349492-A2 ORAL CARE COMPOSITIONS WITH FUSED SILICA The Procter & Gamble Company (US) 2011-08-03 EP disclosed
EP-2349490-A2 WHITENING COMPOSITION WITH FUSED SILICA The Procter & Gamble Company (US) 2011-08-03 EP disclosed
EP-2349190-A1 ORAL CARE COMPOSITIONS WITH IMPROVED AESTHETICS AND FUSED SILICA The Procter & Gamble Company (US) 2011-08-03 EP disclosed
EP-2349491-A2 SENSITIVITY ORAL CARE COMPOSITIONS The Procter & Gamble Company (US) 2011-08-03 EP disclosed
EP-2346475-A1 PERSONAL CARE COMPOSITIONS PROVIDING ENHANCED COOLING SENSATION The Procter & Gamble Company (US) 2011-07-27 EP disclosed
EP-1984001-B1 FIXED-DOSE ASSOCIATION OF PHYTATE AND ZINC UNIV ILLES BALEARS (ES) 2011-07-13 EP disclosed
WO-2011077342-A1 METHOD DANISCO A/S (DK) 2011-06-30 WO disclosed
EP-2318356-A1 SYNTHESIS OF CYCLOHEXANE DERIVATIVES USEFUL AS SENSATES IN CONSUMER PRODUCTS The Procter & Gamble Company (US) 2011-05-11 EP disclosed
EP-2315617-A2 PROCESSING SYSTEM FOR ORAL CARE COMPOSITIONS The Procter & Gamble Company (US) 2011-05-04 EP disclosed
EP-2313070-A1 SOLUTION OF MENTHANE CARBOXAMIDES FOR USE IN CONSUMER PRODUCTS The Procter & Gamble Company (US) 2011-04-27 EP disclosed
US-20110089073-A1 Methods And Compositions For Hydrophobic Modification Of Oral Cavity Surfaces THE PROCTER & GAMBLE COMPANY (US) 2011-04-21 US disclosed
WO-2011031807-A2 METHODS AND COMPOSITIONS FOR HYDROPHOBIC MODIFICATION OF ORAL CAVITY SURFACES THE PROCTER & GAMBLE COMPANY (US) 2011-03-17 WO disclosed
EP-2293850-A2 COMPOSITIONS AND METHODS FOR IMPROVING OVERALL TOOTH HEALTH AND APPEARANCE The Procter & Gamble Company (US) 2011-03-16 EP disclosed
EP-2268258-A1 ORAL CARE COMPOSITIONS The Procter & Gamble Company (US) 2011-01-05 EP disclosed
US-7803353-B2 Oral care compositions having improved consumer aesthetics and taste THE PROCTER & GAMBLE COMPANY (US) 2010-09-28 US disclosed
WO-2010068424-A2 ORAL CARE COMPOSITIONS CONTAINING GEL NETWORKS AND FUSED SILICA THE PROCTER & GAMBLE COMPANY (US) 2010-06-17 WO disclosed
WO-2010068442-A1 IMPROVED CLEANING ORAL CARE COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2010-06-17 WO disclosed
WO-2010068474-A2 ORAL CARE COMPOSITIONS WITH FUSED SILICA THE PROCTER & GAMBLE COMPANY (US) 2010-06-17 WO disclosed
WO-2010068430-A2 ORAL CARE COMPOSITIONS WITH FUSED SILICA THE PROCTER & GAMBLE COMPANY (US) 2010-06-17 WO disclosed
US-20100150846-A1 Method of Making Oral Care Compositions with Fused Silica Slurries THE PROCTER & GAMBLE COMPANY 2010-06-17 US disclosed
US-20100150848-A1 Oral Care Compositions with Chelants and Fused Silica THE PROCTER & GAMBLE COMPANY 2010-06-17 US disclosed
WO-2010068431-A2 ANTIBACTERIAL ORAL CARE COMPOSITIONS WITH FUSED SILICA THE PROCTER & GAMBLE COMPANY (US) 2010-06-17 WO disclosed
WO-2010068440-A2 LOW PH ORAL CARE COMPOSITIONS WITH FUSED SILICA THE PROCTER & GAMBLE COMPANY (US) 2010-06-17 WO disclosed
WO-2010068433-A1 ORAL CARE COMPOSITIONS COMPRISING SPHERICAL FUSED SILICA THE PROCTER & GAMBLE COMPANY (US) 2010-06-17 WO disclosed
WO-2010068471-A2 SENSITIVITY ORAL CARE COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2010-06-17 WO disclosed
WO-2010068428-A1 ORAL CARE COMPOSITIONS WITH IMPROVED AESTHETICS AND FUSED SILICA THE PROCTER & GAMBLE COMPANY (US) 2010-06-17 WO disclosed
WO-2010068444-A2 WHITENING COMPOSITION WITH FUSED SILICA THE PROCTER & GAMBLE COMPANY (US) 2010-06-17 WO disclosed
US-20100135930-A1 Low Ph Oral Care Compositions with Fused Filica THE PROCTER & GAMBLE COMPANY 2010-06-03 US disclosed
US-20100135923-A1 Oral Care Compositions with Fused Silica THE PROCTER & GAMBLE COMPANY 2010-06-03 US disclosed
US-20100136069-A1 Cleaning Oral Care Compositions THE PROCTER & GAMBLE COMPANY 2010-06-03 US disclosed
US-20100135931-A1 Whitening Composition with Fused Silica THE PROCTER & GAMBLE COMPANY 2010-06-03 US disclosed
US-20100135921-A1 Oral Care Compositions with Improved Aesthetics and Fused Silica THE PROCTER & GAMBLE COMPANY 2010-06-03 US disclosed
US-20100135925-A1 Prophy Paste and Weekly Oral Care Compositions THE PROCTER & GAMBLE COMPANY 2010-06-03 US disclosed
US-20100135933-A1 Antibacterial Oral Care Compositions with Fused Silica THE PROCTER & GAMBLE COMPANY 2010-06-03 US disclosed
US-20100135924-A1 Oral Care Compositions Comprising Fused Silica THE PROCTER & GAMBLE COMPANY 2010-06-03 US disclosed
US-20100135929-A1 Oral Care Compositions Containing Gel Networks and Fused Silica THE PROCTER & GAMBLE COMPANY 2010-06-03 US disclosed
US-20100135927-A1 Mild Oral Care Compositions THE PROCTER & GAMBLE COMPANY 2010-06-03 US disclosed
US-20100135928-A1 Oral Care Compositions with Fused Silica THE PROCTER & GAMBLE COMPANY 2010-06-03 US disclosed
US-20100135922-A1 Oral Care Compositions Comprising Spherical Fused Silica THE PROCTER & GAMBLE COMPANY 2010-06-03 US disclosed
US-20100135934-A1 Oral Care Compositions with Abrasive Combinations THE PROCTER & GAMBLE COMPANY 2010-06-03 US disclosed
US-20100135932-A1 Sensitivity Oral Care Compositions THE PROCTER & GAMBLE COMPANY 2010-06-03 US disclosed
WO-2010059289-A1 PERSONAL CARE COMPOSITIONS PROVIDING ENHANCED COOLING SENSATION THE PROCTER & GAMBLE COMPANY (US) 2010-05-27 WO disclosed
US-20100086498-A1 Personal Care Compositions Providing Enhanced Cooling Sensation THE PROCTER & GAMBLE COMPANY 2010-04-08 US disclosed
US-20100076080-A1 Synthesis of Cyclohexane Derivatives Useful as Sensates in Consumer Products THE PROCTER & GAMBLE COMPANY 2010-03-25 US disclosed
WO-2010027721-A2 PROCESSING SYSTEM FOR ORAL CARE COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2010-03-11 WO disclosed
US-20100055052-A1 Processing System for Oral Care Compositions THE PROCTER & GAMBLE COMPANY 2010-03-04 US disclosed
WO-2010019730-A1 SYNTHESIS OF CYCLOHEXANE DERIVATIVES USEFUL AS SENSATES IN CONSUMER PRODUCTS THE PROCTER & GAMBLE COMPANY (US) 2010-02-18 WO disclosed
WO-2010019729-A1 SOLUTION OF MENTHANE CARBOXAMIDES FOR USE IN CONSUMER PRODUCTS THE PROCTER & GAMBLE COMPANY (US) 2010-02-18 WO disclosed
US-20100040563-A1 Solubilization of Cyclohexane-Based Carboxamide Derivatives for Use as Sensates in Consumer Products THE PROCTER & GAMBLE COMPANY 2010-02-18 US disclosed
EP-2144591-A2 PERSONAL CARE COMPOSITIONS COMPRISING AN ANTIMICROBIAL BLEND OF ESSENTIAL OILS OR CONSTITUENTS THEREOF The Procter and Gamble Company (US) 2010-01-20 EP disclosed
WO-2010004361-A2 COMPOSITIONS AND METHODS FOR IMPROVING OVERALL TOOTH HEALTH AND APPEARANCE THE PROCTER & GAMBLE COMPANY (US) 2010-01-14 WO disclosed
EP-2120847-A2 STABLE PEROXIDE CONTAINING PERSONAL CARE COMPOSITIONS The Procter and Gamble Company (US) 2009-11-25 EP disclosed
WO-2009134657-A1 ORAL CARE COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2009-11-05 WO disclosed
US-20090269287-A1 Oral Care Compositions THE PROCTER & GAMBLE COMPANY 2009-10-29 US disclosed
EP-2068814-A1 STANNOUS ORAL CARE COMPOSITIONS The Procter and Gamble Company (US) 2009-06-17 EP disclosed
EP-2054494-A2 FLAVOR OILS WITH REDUCED SULFUR CONTENT AND USE IN ORAL CARE COMPOSITIONS The Procter and Gamble Company (US) 2009-05-06 EP disclosed
EP-2037866-A2 FLAVORS FOR ORAL COMPOSITIONS The Procter and Gamble Company (US) 2009-03-25 EP disclosed
EP-2038012-A2 FLAVOR OILS WITH REDUCED SULFUR CONTENT AND USE IN ORAL CARE COMPOSITIONS The Procter and Gamble Company (US) 2009-03-25 EP disclosed
EP-0958353-B1 PHYTASE POLYPEPTIDES NOVOZYMES AS (DK) 2009-03-04 EP disclosed
US-20090035232-A1 FIXED-DOSE ASSOCIATION OF PHYTATE AND ZINC UNIVERSITAT DE LES ILLES BALEARS (ES) 2009-02-05 US disclosed
CN-101330900-A Oral care compositions comprising zinc and phytate PROCTER & GAMBLE (US) 2008-12-24 CN disclosed
EP-1998743-A1 ORAL CARE COMPOSITIONS PROVIDING ENHANCED WHITENING AND STAIN PREVENTION The Procter and Gamble Company (US) 2008-12-10 EP disclosed
EP-1998738-A1 ORAL CARE COMPOSITIONS HAVING IMPROVED CONSUMER AESTHETICS AND TASTE The Procter and Gamble Company (US) 2008-12-10 EP disclosed
WO-2008126057-A2 PERSONAL CARE COMPOSITIONS COMPRISING AN ANTIMICROBIAL BLEND OF ESSENTIAL OILS OR CONSTITUENTS THEREOF THE PROCTER & GAMBLE COMPANY (US) 2008-10-23 WO disclosed
US-20080253976-A1 Personal Care Compositions Comprising An Antimicrobial Blend of Essential Oils or Constituents Thereof THE PROCTER & GAMBLE COMPANY 2008-10-16 US disclosed
US-20080247973-A1 Compositions and Methods for Improving Overall Tooth Health and Appearance THE PROCTER & GAMBLE COMPANY 2008-10-09 US disclosed
EP-1962787-A2 ORAL CARE COMPOSITIONS COMPRISING ZINC AND PHYTATE The Procter and Gamble Company (US) 2008-09-03 EP disclosed
EP-1962787-A2 ORAL CARE COMPOSITIONS COMPRISING ZINC AND PHYTATE The Procter and Gamble Company (US) 2008-09-03 EP disclosed
US-20080175801-A1 Stable peroxide containing personal care compositions THE PROCTER & GAMBLE COMPANY 2008-07-24 US disclosed
WO-2008087609-A2 STABLE PEROXIDE CONTAINING ORAL CARE COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2008-07-24 WO disclosed
US-20080138298-A1 Oral care compositions comprising zinc and phytate THE PROCTER & GAMBLE COMPANY 2008-06-12 US disclosed
US-20080138298-A1 Oral care compositions comprising zinc and phytate THE PROCTER & GAMBLE COMPANY 2008-06-12 US disclosed
WO-2008041055-A1 STANNOUS ORAL CARE COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2008-04-10 WO disclosed
WO-2008005549-A2 FLAVOR OILS WITH REDUCED SULFUR CONTENT AND USE IN ORAL CARE COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2008-01-10 WO disclosed
US-20080008667-A1 Flavor oils with reduced sulfur content and use in oral care compositions THE PROCTER & GAMBLE COMPANY 2008-01-10 US disclosed
US-20080008665-A1 Flavors for oral compositions THE PROCTER & GAMBLE COMPANY 2008-01-10 US disclosed
WO-2008005548-A2 FLAVORS FOR ORAL COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2008-01-10 WO disclosed
WO-2008005550-A2 FLAVOR OILS WITH REDUCED SULFUR CONTENT AND USE IN ORAL CARE COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2008-01-10 WO disclosed
US-20080008729-A1 Flavor oils with reduced sulfur content and use in oral care compositions THE PROCTER & GAMBLE COMPANY 2008-01-10 US disclosed
CN-101076587-A Inositol polyphosphate 2-kinase gene and use thereof DOW AGROSCIENCES LLC (US) 2007-11-21 CN disclosed
WO-2007110790-A1 ORAL CARE COMPOSITIONS HAVING IMPROVED CONSUMER AESTHETICS AND TASTE THE PROCTER & GAMBLE COMPANY (US) 2007-10-04 WO disclosed
WO-2007111616-A1 ORAL CARE COMPOSITIONS PROVIDING ENHANCED WHITENING AND STAIN PREVENTION THE PROCTER & GAMBLE COMPANY (US) 2007-10-04 WO disclosed
US-20070231278-A1 Oral care compositions having improved consumer aesthetics and taste THE PROCTER & GAMBLE COMPANY 2007-10-04 US disclosed
WO-2007076001-A3 ORAL CARE COMPOSITIONS COMPRISING ZINC AND PHYTATE PROCTER & GAMBLE (US) 2007-09-07 WO disclosed
WO-2007076001-A2 ORAL CARE COMPOSITIONS COMPRISING ZINC AND PHYTATE THE PROCTER & GAMBLE COMPANY (US) 2007-07-05 WO disclosed
WO-2007076001-A2 ORAL CARE COMPOSITIONS COMPRISING ZINC AND PHYTATE THE PROCTER & GAMBLE COMPANY (US) 2007-07-05 WO disclosed
US-7238350-B2 Phytase polypeptides NOROZYMES A/S (DK) 2007-07-03 US disclosed
US-20070025928-A1 Stannous oral care compositions THE PROCTER & GAMBLE COMPANY 2007-02-01 US disclosed
US-20060171907-A1 Oral care compositions providing enhanced whitening and stain prevention THE PROCTER & GAMBLE COMPANY 2006-08-03 US disclosed
WO-2006063588-A1 POLYPEPTIDES HAVING ACID PHOSPHATASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME NOVOZYMES A/S (DK) 2006-06-22 WO disclosed
US-20060035810-A1 Regulation of ins(3456)p4 signalling by a reversible kinase phosphatase and methods and compositions related thereto HEALTH AND HUMAN SERVICES NATIONAL INSTITUTES OF HEALTH, UNITED STATES OF AMERICA, THE, AS REPRESENTED BY THE SECRETARY 2006-02-16 US disclosed
US-6569659-B1 Basidiomycetes; consensus sequences; use in industrial applications NOVOZYMES A/S (DK) 2003-05-27 US disclosed
US-20030064497-A1 Phytase polypeptides NOVOZYMES A/S (DK) 2003-04-03 US disclosed
US-6039942-A POLYPEPTIDES WITH AMINO ACID SEQUENCES NOVO NORDICK A/S (DK) 2000-03-21 US disclosed
EP-0958353-A1 PHYTASE POLYPEPTIDES NOVO NORDISK A/S (DK) 1999-11-24 EP disclosed
US-5977078-A CELL PERMEABLE ANTAGONIST THE REGENTS OF THE UNIVESITY OF CALIFORNIA (US) 1999-11-02 US disclosed
WO-1998030681-A1 PHYTASE COMBINATIONS NOVO NORDISK A/S (DK) 1998-07-16 WO disclosed
WO-1998028409-A1 PHYTASE POLYPEPTIDES NOVO NORDISK A/S (DK) 1998-07-02 WO disclosed
EP-0616520-B1 PHYTATE-ANTIMICROBIAL COMPOSITIONS IN ORAL CARE PRODUCTS DOW CHEMICAL CO (US) 1996-05-29 EP disclosed
EP-0616519-A1 ORAL COMPOSITIONS FOR SUPPRESSING MOUTH ODORS THE DOW CHEMICAL COMPANY (US) 1994-09-28 EP disclosed
EP-0616520-A1 PHYTATE-ANTIMICROBIAL COMPOSITIONS IN ORAL CARE PRODUCTS. DOW CHEMICAL CO (US) 1994-09-28 EP disclosed
US-5300289-A Cationic microbiocide and compatibilizer THE DOW CHEMICAL COMPANY (US) 1994-04-05 US disclosed
US-5292913-A Labeling with deuterium or tritium MITSUI TOATSU CHEMICALS, INCORPORATED (JP) 1994-03-08 US disclosed
US-5286479-A Copper salt; phytic acid; cationic antimicrobial compound; compatibilizing agent to enhance retention to hydroxyapatite surface THE DOW CHEMICAL COMPANY (US) 1994-02-15 US disclosed
WO-1993011739-A1 ORAL COMPOSITIONS FOR SUPPRESSING MOUTH ODORS THE DOW CHEMICAL COMPANY (US) 1993-06-24 WO disclosed
WO-1993011740-A1 PHYTATE-ANTIMICROBIAL COMPOSITIONS IN ORAL CARE PRODUCTS THE DOW CHEMICAL COMPANY (US) 1993-06-24 WO disclosed
US-4952717-A Myoinositol derivatives and preparation process thereof MITSUI TOATSU CHEMICALS, INCORPORATED (JP) 1990-08-28 US disclosed
US-4952717-A Myoinositol derivatives and preparation process thereof MITSUI TOATSU CHEMICALS, INCORPORATED (JP) 1990-08-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (50 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11826452-B2 Reduction of tooth staining derived from cationic antimicrobials PHOSPHO1, PEF1, DNM1L ITPR3 1374/4885ITPR2 2911/4885ITPR1 2645/4885
US-20140186272-A1 SYNTHESIS OF CYCLOHEXANE DERIVATIVES USEFUL AS SENSATES IN CONSUMER PRODUCTS NISCH, TRPM4, TRPM8 ITPR3 268/4885ITPR2 917/4885ITPR1 694/4885
US-20080008665-A1 Flavors for oral compositions TAS2R20, TAS2R10, TAS2R16 ITPR3 1581/4885ITPR2 2181/4885ITPR1 1817/4885
US-20230138092-A1 Oral Care Compositions DSC1, MAPT, PSEN1 ITPR3 540/4885ITPR2 763/4885ITPR1 609/4885
US-20220387273-A1 Oral Care Compositions DSC1, SLC6A12, OTC ITPR3 818/4885ITPR2 1093/4885ITPR1 771/4885
US-11160828-B2 Iron-fortified food composition TFRC, LCT, FTH1 ITPR3 131/4885ITPR2 187/4885ITPR1 159/4885
US-20070231278-A1 Oral care compositions having improved consumer aesthetics and taste TAS2R5, TAS2R4, TAS1R2 ITPR3 2117/4885ITPR2 3207/4885ITPR1 3744/4885
US-20190175487-A1 Oral Care Compositions PPIP5K2, PHOSPHO1, VCL ITPR3 328/4885ITPR2 483/4885ITPR1 432/4885
US-20240173226-A1 Oral Care Compositions SLC30A7, SLC39A7, S100A9 ITPR3 373/4885ITPR2 496/4885ITPR1 411/4885
US-20220016161-A1 IRON-FORTIFIED FOOD COMPOSITION TFRC, FTH1, HAMP ITPR3 36/4885ITPR2 80/4885ITPR1 60/4885
US-20070025928-A1 Stannous oral care compositions SOD1, MAL2, TAS2R42 ITPR3 320/4885ITPR2 412/4885ITPR1 442/4885
US-20180168978-A1 Oral Care Compositions ARGLU1, SLC30A7, ARG1 ITPR3 362/4885ITPR2 858/4885ITPR1 635/4885
US-20090035232-A1 FIXED-DOSE ASSOCIATION OF PHYTATE AND ZINC SLC30A5, PTH1R, SLC39A7 ITPR3 68/4885ITPR2 147/4885ITPR1 109/4885
US-20110089073-A1 Methods And Compositions For Hydrophobic Modification Of Oral Cavity Surfaces PTMS, TAS2R39, CASP3 ITPR3 880/4885ITPR2 1754/4885ITPR1 1630/4885
US-20230363991-A1 Oral Care Compositions DSC1, SLC6A12, OTC ITPR3 818/4885ITPR2 1093/4885ITPR1 771/4885
US-20220047484-A1 Reduction Of Tooth Staining Derived From Cationic Antimicrobials PHOSPHO1, PEF1, DNM1L ITPR3 1374/4885ITPR2 2911/4885ITPR1 2645/4885
US-10617140-B2 Iron-fortified food composition HAMP, SLC40A1, FTH1 ITPR3 15/4885ITPR2 48/4885ITPR1 30/4885
US-20190117542-A1 Oral Care Compositions ARGLU1, SLC30A7, ARG1 ITPR3 362/4885ITPR2 858/4885ITPR1 635/4885
US-20100040563-A1 Solubilization of Cyclohexane-Based Carboxamide Derivatives for Use as Sensates in Consumer Products CUTA, TAS2R8, TAS2R38 ITPR3 3066/4885ITPR2 3777/4885ITPR1 4014/4885
US-10123953-B2 Reduction of tooth staining derived from cationic antimicrobials SOD1, ZRANB2, SLC30A5 ITPR3 2278/4885ITPR2 2763/4885ITPR1 3083/4885
US-20230201098-A1 Oral Care Compositions VCL, MVD, ARG1 ITPR3 1764/4885ITPR2 2577/4885ITPR1 2681/4885
US-20080247973-A1 Compositions and Methods for Improving Overall Tooth Health and Appearance ALPP, CHERP, CA3 ITPR3 87/4885ITPR2 173/4885ITPR1 177/4885
US-20200170902-A1 REDUCTION OF TOOTH STAINING DERIVED FROM CATIONIC ANTIBACTERIALS SOD1, ZRANB2, HDAC10 ITPR3 2820/4885ITPR2 3259/4885ITPR1 3506/4885
US-20140056994-A1 Fixed-Dose Association of Phytate and Zinc PTH1R, SLC30A5, SLC39A7 ITPR3 82/4885ITPR2 171/4885ITPR1 132/4885
US-20220401321-A1 Oral Care Compositions TUBGCP3, TUBGCP4, TUBGCP2 ITPR3 661/4885ITPR2 951/4885ITPR1 636/4885
US-20030064497-A1 Phytase polypeptides PPA1, PMM2, IPMK ITPR3 99/4885ITPR2 200/4885ITPR1 139/4885
US-11590163-B2 Iron-fortified food composition TFRC, FTH1, HAMP ITPR3 36/4885ITPR2 80/4885ITPR1 60/4885
US-20100086498-A1 Personal Care Compositions Providing Enhanced Cooling Sensation TRPA1, TRPV1, TRPM2 ITPR3 61/4885ITPR2 83/4885ITPR1 74/4885
US-20180168964-A1 Oral Care Compositions SLC39A3, SFXN3, NFXL1 ITPR3 953/4885ITPR2 1556/4885ITPR1 1080/4885
US-20140377194-A1 Stain-Proof Oral Care Composition ALPL, ALPP, H1-5 ITPR3 965/4885ITPR2 1363/4885ITPR1 1083/4885
US-20080008729-A1 Flavor oils with reduced sulfur content and use in oral care compositions MPST, TST, TAS2R40 ITPR3 3765/4885ITPR2 4063/4885ITPR1 3343/4885
US-20090269287-A1 Oral Care Compositions DSC1, GALC, TAS2R39 ITPR3 994/4885ITPR2 1900/4885ITPR1 1746/4885
US-11253451-B2 Reduction of tooth staining derived from cationic antibacterials SOD1, ZRANB2, HDAC10 ITPR3 2820/4885ITPR2 3259/4885ITPR1 3506/4885
US-20060171907-A1 Oral care compositions providing enhanced whitening and stain prevention PPIP5K2, PHOSPHO1, PTEN ITPR3 73/4885ITPR2 230/4885ITPR1 163/4885
US-20100055052-A1 Processing System for Oral Care Compositions DSC1, SMCHD1, TAS2R39 ITPR3 3089/4885ITPR2 3986/4885ITPR1 3647/4885
US-20240000811-A1 INOSITOL HEXAKISPHOSPHATE ANALOGUES FOR TREATMENT OF CALCIFICATION ASSOCIATED KIDNEY DISEASES PPIP5K2, INPP5B, IP6K3 ITPR3 5/4885ITPR2 6/4885ITPR1 8/4885
US-20240100074-A1 Clinical Dosing Schedule of Inositol Phosphate Oligo(Ethylene Glycol) Compounds PPIP5K2, IPMK, INPP5B ITPR3 6/4885ITPR2 9/4885ITPR1 8/4885
US-20080175801-A1 Stable peroxide containing personal care compositions PPOX, LPO, SOD1 ITPR3 1532/4885ITPR2 2386/4885ITPR1 1957/4885
US-20170281490-A1 REDUCTION OF TOOTH STAINING DERIVED FROM CATIONIC ANTIBACTERIALS SOD1, ZRANB2, HDAC10 ITPR3 2820/4885ITPR2 3259/4885ITPR1 3506/4885
US-11752075-B2 Oral care compositions DSC1, SLC6A12, OTC ITPR3 818/4885ITPR2 1093/4885ITPR1 771/4885
US-20100076080-A1 Synthesis of Cyclohexane Derivatives Useful as Sensates in Consumer Products NISCH, TRPM4, TRPM8 ITPR3 268/4885ITPR2 917/4885ITPR1 694/4885
US-20190175486-A1 Oral Care Compositions VCL, MVD, ARG1 ITPR3 1764/4885ITPR2 2577/4885ITPR1 2681/4885
US-20110239736-A1 Whole Mouth Malador Control By A Combination Of Antibacterial And Deodorizing Agents OR10J3, HDAC10, RPP30 ITPR3 2655/4885ITPR2 3361/4885ITPR1 2833/4885
US-20230201099-A1 Oral Care Compositions PPIP5K2, PHOSPHO1, VCL ITPR3 328/4885ITPR2 483/4885ITPR1 432/4885
US-20080008667-A1 Flavor oils with reduced sulfur content and use in oral care compositions MPST, TST, TAS2R40 ITPR3 3765/4885ITPR2 4063/4885ITPR1 3343/4885
US-10195128-B2 Oral care compositions ARGLU1, SLC30A7, ARG1 ITPR3 362/4885ITPR2 858/4885ITPR1 635/4885
US-20130344011-A1 Reduction Of Tooth Staining Derived From Cationic Antimicrobials SOD1, ZRANB2, SLC30A5 ITPR3 2278/4885ITPR2 2763/4885ITPR1 3083/4885
US-20200337972-A1 Reduction Of Tooth Staining Derived From Cationic Antimicrobials PHOSPHO1, PEF1, DNM1L ITPR3 1374/4885ITPR2 2911/4885ITPR1 2645/4885
US-11191709-B2 Reduction of tooth staining derived from cationic antimicrobials PHOSPHO1, PEF1, DNM1L ITPR3 1374/4885ITPR2 2911/4885ITPR1 2645/4885
US-10596086-B2 Reduction of tooth staining derived from cationic antibacterials SOD1, ZRANB2, HDAC10 ITPR3 2820/4885ITPR2 3259/4885ITPR1 3506/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.